Govt forms 5-member committee to review pharma marketing practices

Govt forms 5-member committee to review pharma marketing practices – The central government has a five-member committee, aimed at considering a “legally enforceable” mechanism for regulating the marketing practices of pharmaceutical firms. V K Paul, member (health) of NITI Aayog has been elected as the head of the committee.

• The committee will submit its report in 90 days.
• It will help in examining the provisions government departments have to regulate pharmaceutical marketing practices and align interventions for implementation by the healthcare industry.

The members of the committee

• V K Paul, member (health) of NITI Aayog – Chairman of the committee
• S Aparna, secretary in department of pharmaceuticals (DoP);
• Rajesh Bhushan, secretary in the ministry of health and family welfare (MoHFW);
• Nitin Gupta, chairman of the Central Board of Direct Taxes (CBDT);
• a joint secretary (policy) from the department of personnel (DoP)

Universal Code of Pharmaceutical Marketing Practices (UCPMP)

• The DoP’s Universal Code of Pharmaceutical Marketing Practices (UCPMP) for pharmaceutical firms came into effect in January 2015.
• As per the UCPMP, Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which comes under the Medical Council Act, 1956 details the relationship between healthcare professionals and pharmaceutical companies.

******** End ********

★★★★  You Can Also Read  ★★★★

📣 Prepare Exams is now on Facebook, Twitter, Instagram, YouTube Channel, and Google News to get all the latest News